• 1
    Bleyer W, Barr R. Highlights and challenges. In: Bleyer A, O'Leary M, Barr R, et al, eds. Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of age, Including SEER Incidence and Survival, 1975 to 2000. NIH Pub. No. 06-5767. Bethesda, MD: National Cancer Institute; 2006.
  • 2
    Fern L, Davies S, Eden T, et al. Rates of inclusion of teenagers and young adults in England into National Cancer Research Network clinical trials: report from the National Cancer Research Institute (NCRI) Teenage and Young Adult Clinical Studies Development Group. Br J Cancer. 2008; 99: 1967-1974.
  • 3
    McTiernan A. Issues surrounding the participation of adolescents with cancer in clinical trials in the UK. Eur J Cancer. Care. 2003; 12: 233-239.
  • 4
    Shaw PH, Ritchey AK. Different rates of clinical trial enrollment between adolescents and young adults aged 15 to 21 years-old and children under 15 years-old with cancer at a children's hospital. J Pediatr Hematol Oncol. 2007; 29: 811-814.
  • 5
    Downs-Canner S, Shaw PH. A comparison of clinical trial enrollment between adolescent and young adult (AYA) oncology patients treated at affiliated adult and pediatric oncology centers. J Pediatr Hematol Oncol. 2009; 31: 927-929.
  • 6
    Bleyer A, Montello M, Budd T, et al. National survival trends of young adults with sarcoma: lack of progress is associated with lack of clinical trial participation. Cancer. 2005; 103: 1891-1897.
  • 7
    Bleyer A, Montello M, Budd T. Young adults with leukemia in the United States: lack of clinical trial participation and mortality reduction during the last decade [abstract]. Proc Am Soc Clin Oncol. 2004; 23: 586.
  • 8
    Yeager ND, Hoshaw-Woodard S, Ruymann FB, et al. Patterns of care among adolescents with malignancy in Ohio. J Pediat Hematol Oncol. 2006; 28: 17-22.